Literature DB >> 21207958

Deconstruction of non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 for exploration of the optimization landscape of fragments.

Peter Brandt1, Matthis Geitmann, U Helena Danielson.   

Abstract

This study has taken a closer look at the theoretical basis for protein-fragment interactions. The approach involved the deconstruction of 3 non-nucleoside inhibitors of HIV-1 reverse transcriptase and investigation of the interaction between 21 substructures and the enzyme. It focused on the concept of ligand efficiency and showed that ligand independent free energy fees (ΔG(ind)) are crucial for the understanding of the binding affinities of fragments. A value of 7.0 kcal mol(-1) for the ΔG(ind) term is shown to be a lower limit for the NNRTI binding pocket of HIV-1 RT. The addition of the ΔG(ind) term to the dissociation free energy in the calculation of a corrected ligand efficiency, in combination with the lack of an efficient ligand binding hot spot in the NNIBP, fully explains the existence of nonbinding NNRTI substructures. By applying the concept to a larger set of ligands, we could define a binding site profile that indicates the absence of an efficient fragment binding hot spot but an efficient binding of full-sized NNRTIs. The analysis explains some of the challenges in identifying fragments against flexible targets involving conformational changes and how fragments may be prioritized.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207958     DOI: 10.1021/jm101052g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Ligand deconstruction: Why some fragment binding positions are conserved and others are not.

Authors:  Dima Kozakov; David R Hall; Stefan Jehle; Sefan Jehle; Lingqi Luo; Stefan O Ochiana; Elizabeth V Jones; Michael Pollastri; Karen N Allen; Adrian Whitty; Sandor Vajda
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

Review 2.  Fragment screening and HIV therapeutics.

Authors:  Joseph D Bauman; Disha Patel; Eddy Arnold
Journal:  Top Curr Chem       Date:  2012

3.  Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening.

Authors:  Joseph D Bauman; Disha Patel; Chhaya Dharia; Marc W Fromer; Sameer Ahmed; Yulia Frenkel; R S K Vijayan; J Thomas Eck; William C Ho; Kalyan Das; Aaron J Shatkin; Eddy Arnold
Journal:  J Med Chem       Date:  2013-02-20       Impact factor: 7.446

4.  Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.

Authors:  Madeline E Kavanagh; Janine L Gray; Sophie H Gilbert; Anthony G Coyne; Kirsty J McLean; Holly J Davis; Andrew W Munro; Chris Abell
Journal:  ChemMedChem       Date:  2016-07-19       Impact factor: 3.466

5.  Discovery of fragments inducing conformational effects in dynamic proteins using a second-harmonic generation biosensor.

Authors:  Edward A FitzGerald; Margaret T Butko; Pierre Boronat; Daniela Cederfelt; Mia Abramsson; Hildur Ludviksdottir; Jacqueline E van Muijlwijk-Koezen; Iwan J P de Esch; Doreen Dobritzsch; Tracy Young; U Helena Danielson
Journal:  RSC Adv       Date:  2021-02-17       Impact factor: 3.361

6.  Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA.

Authors:  Federica Prati; Fabio Zuccotto; Daniel Fletcher; Maire A Convery; Raquel Fernandez-Menendez; Robert Bates; Lourdes Encinas; Jingkun Zeng; Chun-Wa Chung; Paco De Dios Anton; Alfonso Mendoza-Losana; Claire Mackenzie; Simon R Green; Margaret Huggett; David Barros; Paul G Wyatt; Peter C Ray
Journal:  ChemMedChem       Date:  2018-02-19       Impact factor: 3.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.